Anti-Gram-Positive Bacterial Library

Catalog No. L4522

Gram-positive bacteria are a group of bacteria that appear purple in the Gram staining test. They have thick cell walls rich in peptidoglycan and lack an outer membrane structure. Common pathogenic Gram-positive bacteria include *Staphylococcus aureus*, methicillin-resistant *Staphylococcus aureus* (MRSA), *Streptococcus pneumoniae*, *Enterococcus* spp., and *Bacillus anthracis*. These pathogens can cause a variety of serious diseases such as skin and soft tissue infections, pneumonia, sepsis, and endocarditis, and hold significant clinical relevance in both hospital-acquired and community-acquired infections.
With the widespread use of antibiotics, the issue of antibiotic resistance in Gram-positive bacteria has become increasingly severe. In particular, the emergence and spread of “superbugs” such as MRSA and vancomycin-resistant enterococci (VRE) have greatly reduced the efficacy of traditional antibiotics, including β-lactams, macrolides, and even glycopeptides, leading to higher treatment failure rates and increased mortality risk. There is an urgent need to develop novel, effective, and safe anti-Gram-positive bacterial agents.
The TargetMol’s anti-gram-positive bacteria compound library contains 275 small-molecule compounds with activity against Gram-positive bacteria. It serves as a powerful tool for antibacterial drug research, aiming to provide high-quality lead compound resources to overcome the challenge of drug resistance.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.